221 related articles for article (PubMed ID: 35484119)
21. Neuropeptide Y promotes hepatic apolipoprotein A1 synthesis and secretion through neuropeptide Y Y5 receptor.
Liu B; Chen F
Peptides; 2022 Aug; 154():170824. PubMed ID: 35660638
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological inhibition of neuropeptide Y receptors Y1 and Y5 reduces hypoxic breast cancer migration, proliferation, and signaling.
Pascetta SA; Kirsh SM; Cameron M; Uniacke J
BMC Cancer; 2023 Jun; 23(1):494. PubMed ID: 37264315
[TBL] [Abstract][Full Text] [Related]
23. The mPVN mediates blockade of NPY-induced feeding by a Y5 receptor antagonist: a c-FOS analysis.
Yokosuka M; Dube MG; Kalra PS; Kalra SP
Peptides; 2001 Mar; 22(3):507-14. PubMed ID: 11287108
[TBL] [Abstract][Full Text] [Related]
24. Involvement of neuropeptide Y and its Y1 and Y5 receptors in maintaining self-renewal and proliferation of human embryonic stem cells.
Son MY; Kim MJ; Yu K; Koo DB; Cho YS
J Cell Mol Med; 2011 Jan; 15(1):152-65. PubMed ID: 19874423
[TBL] [Abstract][Full Text] [Related]
25. Neuropeptide Y and its receptors in prostate cancer: associations with cancer invasiveness and perineural spread.
Sigorski D; Wesołowski W; Gruszecka A; Gulczyński J; Zieliński P; Misiukiewicz S; Kitlińska J; Iżycka-Świeszewska E
J Cancer Res Clin Oncol; 2023 Aug; 149(9):5803-5822. PubMed ID: 36583743
[TBL] [Abstract][Full Text] [Related]
26. Placental Neuropeptide Y ( NPY) and NPY receptors expressions and serum NPY levels in preeclampsia.
Klinjampa R; Sitticharoon C; Souvannavong-Vilivong X; Sripong C; Keadkraichaiwat I; Churintaraphan M; Chatree S; Lertbunnaphong T
Exp Biol Med (Maywood); 2019 Apr; 244(5):380-388. PubMed ID: 30760028
[TBL] [Abstract][Full Text] [Related]
27. Activation of Neuropeptide Y Receptors Modulates Retinal Ganglion Cell Physiology and Exerts Neuroprotective Actions In Vitro.
Martins J; Elvas F; Brudzewsky D; Martins T; Kolomiets B; Tralhão P; Gøtzsche CR; Cavadas C; Castelo-Branco M; Woldbye DP; Picaud S; Santiago AR; Ambrósio AF
ASN Neuro; 2015; 7(4):. PubMed ID: 26311075
[TBL] [Abstract][Full Text] [Related]
28. Neuropeptide Y Stimulates Proliferation and Migration of Vascular Smooth Muscle Cells from Pregnancy Hypertensive Rats via Y1 and Y5 Receptors.
Zhang P; Qi YX; Yao QP; Chen XH; Wang GL; Shen BR; Han Y; Gao LZ; Jiang ZL
PLoS One; 2015; 10(7):e0131124. PubMed ID: 26131716
[TBL] [Abstract][Full Text] [Related]
29. NPY and Y receptors: lessons from transgenic and knockout models.
Lin S; Boey D; Herzog H
Neuropeptides; 2004 Aug; 38(4):189-200. PubMed ID: 15337371
[TBL] [Abstract][Full Text] [Related]
30. Characterization of the neuropeptide Y system in the frog Silurana tropicalis (Pipidae): three peptides and six receptor subtypes.
Sundström G; Xu B; Larsson TA; Heldin J; Bergqvist CA; Fredriksson R; Conlon JM; Lundell I; Denver RJ; Larhammar D
Gen Comp Endocrinol; 2012 Jul; 177(3):322-31. PubMed ID: 22565163
[TBL] [Abstract][Full Text] [Related]
31. The identification of neuropeptide Y receptor subtype involved in phenylpropanolamine-induced increase in oxidative stress and appetite suppression.
Hsieh YS; Kuo MH; Chen PN; Kuo DY
Neuromolecular Med; 2013 Mar; 15(1):159-68. PubMed ID: 23179670
[TBL] [Abstract][Full Text] [Related]
32. Role of the Y5 neuropeptide Y receptor in limbic seizures.
Marsh DJ; Baraban SC; Hollopeter G; Palmiter RD
Proc Natl Acad Sci U S A; 1999 Nov; 96(23):13518-23. PubMed ID: 10557353
[TBL] [Abstract][Full Text] [Related]
33. Antiepileptic actions of neuropeptide Y in the mouse hippocampus require Y5 receptors.
Baraban SC
Epilepsia; 2002; 43 Suppl 5():9-13. PubMed ID: 12121287
[TBL] [Abstract][Full Text] [Related]
34. Combined gene overexpression of neuropeptide Y and its receptor Y5 in the hippocampus suppresses seizures.
Gøtzsche CR; Nikitidou L; Sørensen AT; Olesen MV; Sørensen G; Christiansen SH; Ängehagen M; Woldbye DP; Kokaia M
Neurobiol Dis; 2012 Jan; 45(1):288-96. PubMed ID: 21884793
[TBL] [Abstract][Full Text] [Related]
35. NPY regulation of bone remodelling.
Lee NJ; Herzog H
Neuropeptides; 2009 Dec; 43(6):457-63. PubMed ID: 19748118
[TBL] [Abstract][Full Text] [Related]
36. Levetiracetam prevents changes in levels of brain-derived neurotrophic factor and neuropeptide Y mRNA and of Y1- and Y5-like receptors in the hippocampus of rats undergoing amygdala kindling: implications for antiepileptogenic and mood-stabilizing properties.
Husum H; Bolwig TG; Sánchez C; Mathé AA; Hansen SL
Epilepsy Behav; 2004 Apr; 5(2):204-15. PubMed ID: 15123022
[TBL] [Abstract][Full Text] [Related]
37. BODIPY-conjugated neuropeptide Y ligands: new fluorescent tools to tag Y1, Y2, Y4 and Y5 receptor subtypes.
Dumont Y; Gaudreau P; Mazzuferi M; Langlois D; Chabot JG; Fournier A; Simonato M; Quirion R
Br J Pharmacol; 2005 Dec; 146(8):1069-81. PubMed ID: 16231000
[TBL] [Abstract][Full Text] [Related]
38. Long-Term Over-Expression of Neuropeptide Y in Hypothalamic Paraventricular Nucleus Contributes to Adipose Tissue Insulin Resistance Partly via the Y5 Receptor.
Long M; Zhou J; Li D; Zheng L; Xu Z; Zhou S
PLoS One; 2015; 10(5):e0126714. PubMed ID: 25993471
[TBL] [Abstract][Full Text] [Related]
39. A Y2 receptor mimetic aptamer directed against neuropeptide Y.
Proske D; Höfliger M; Söll RM; Beck-Sickinger AG; Famulok M
J Biol Chem; 2002 Mar; 277(13):11416-22. PubMed ID: 11756401
[TBL] [Abstract][Full Text] [Related]
40. Neuropeptide Y and its Y2 receptor: potential targets in neuroblastoma therapy.
Lu C; Everhart L; Tilan J; Kuo L; Sun CC; Munivenkatappa RB; Jönsson-Rylander AC; Sun J; Kuan-Celarier A; Li L; Abe K; Zukowska Z; Toretsky JA; Kitlinska J
Oncogene; 2010 Oct; 29(41):5630-42. PubMed ID: 20676138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
